CION Ameerpet
Once a specific variant has been identified in your family, testing a relative for that exact change is quick, inexpensive and gives a clear yes or no. The technical part is easy. Telling people is the part that takes something.
The original search for a hereditary cause is genuinely difficult. It means sequencing whole genes, sometimes a panel of a dozen or more, and interpreting every change found against what is known about which changes matter. It takes weeks and it is expensive.
Once a specific variant has been found, everything changes. Testing a relative is no longer a search — it is a single targeted question: does this person carry this exact change, yes or no? That is fast, considerably cheaper, and the answer is unambiguous. There is no variant of uncertain significance to wrestle with, because the meaning of this particular change has already been established.
This is what cascade testing means: working outward from the person in whom the variant was first identified, through siblings and children, then through cousins and further relatives as each positive result opens a new branch. In principle it is one of the most efficient things in preventive medicine. In practice, what limits it is almost never the science.
Finding a variant in the first place means sequencing whole genes and interpreting every change. Testing for a known one does not.
One targeted question, a definite yes or no, and no uncertain results to interpret.
From the index case through siblings and children, then further with each positive result.
Inherited cancer variants do not skip generations, which is a persistent and consequential misunderstanding. If you test negative for your family's known variant, you cannot pass it to your children — the chain stops with you. What can look like skipping is a carrier who never developed cancer: a variant raises risk rather than guaranteeing disease, and a man in particular may carry a BRCA variant, remain entirely well, and pass it to half his children. The family appears to skip a generation because nobody in it fell ill, not because the gene did. Source: NCCN Genetic/Familial High-Risk Assessment guidelines.
There is no perfect way to do this, but some approaches consistently work better than others.
Obtain your own full report — the document naming the specific variant, usually in a technical notation. This is what relatives' testing will target, and handing them the actual document removes any risk of the detail being garbled as it passes along. Ask your genetics service for a family letter as well; most provide one written specifically to be passed on.
Siblings and adult children first, since each has a fifty per cent chance. Within that, there is a case for prioritising those for whom it changes something soon — a sister approaching the age at which risk-reducing surgery would be discussed, or a daughter making reproductive decisions.
The most useful framing is that this is information about risk, not a diagnosis, and that carrying a variant does not mean developing cancer. Being clear that effective options exist — and that a negative result returns them to ordinary population risk — makes the conversation considerably easier to receive.
Tell them who to contact and give them the family letter and the variant details. A relative who has been told something worrying but not how to act on it is left worse off than before. Making the next step obvious is the single most useful thing you can do.
Some will test immediately. Some will thank you and do nothing for years. Some will be angry with you, which is usually displaced fear rather than anything about you. Some will refuse outright. None of these is your fault and none is within your control.
Your responsibility is making the information available in a form people can act on. It is not making them act. Repeatedly pressing a relative who has said no tends to entrench the refusal and damage the relationship, and it does not produce tests.
Ask your genetics service for a family letter. It is written to be passed on, states the variant precisely, and means you do not have to explain the science yourself.
These questions arise constantly and are rarely covered in a standard appointment.
For adult-onset cancer predispositions such as BRCA, testing is generally deferred until a person is an adult and can decide for themselves. The reasoning is that nothing would be done differently in childhood — surveillance does not begin until the twenties at the earliest — so testing a child removes their future choice without offering any benefit in return.
Lynch syndrome is broadly similar, with surveillance beginning in adulthood. Where a young adult is approaching the age at which surveillance or decisions would start, that is the natural point to raise it. Telling children that a variant runs in the family, without testing them, is a separate and often earlier conversation.
This is common and there is no clean solution. Where direct contact is impossible or unwelcome, options include asking another relative to pass the letter on, writing rather than calling, or sending the family letter with a brief note that makes no demand and simply provides the information.
Genetics services are used to this and can advise. What matters is that you have made a reasonable effort to make the information available. You are not obliged to repair a relationship in order to deliver a health message, and it is not a failure if someone cannot be reached.
This is a legitimate choice and it should be respected. People decline for varied and often sensible reasons — they would not act differently, they are managing something else, they know themselves and how they would live with the knowledge.
The one thing worth ensuring is that the refusal is informed: that they know effective options exist and that a negative result would return them to population risk. After that, the decision is theirs. It can be revisited later, and many people who decline initially come back years afterwards.
If your aunt carries a variant, your own risk depends on whether your parent — her sibling — inherited it. Testing that parent first is often the more efficient route: if they are negative, you and your siblings need no testing at all, and the branch closes.
This gets complicated when the parent does not want to be tested but you do, since testing you may reveal their status indirectly. Genetics services handle this regularly and there are ways through it, but it is worth raising explicitly rather than discovering the complication midway.
This worry comes up frequently and deserves a straight answer: the position varies by country and by insurer, and it is not something to guess at. Ask your genetics service what applies where you live, and ask before testing rather than afterwards.
It is worth noting separately that a strong family history may itself be relevant to some insurance applications regardless of whether you test — so declining a test does not necessarily avoid the question. This is precisely the kind of thing pre-test counselling exists to cover.
This deserves emphasis because it is frequently underplayed. A relative who tests negative for a known familial variant is a true negative: they have not inherited the family's variant, their risk returns to that of the general population, and they can stop the enhanced surveillance and worry that a family history brings.
They also cannot pass the variant to their children, so that branch of the family closes. For many families, the relief delivered by negative results is the larger part of what cascade testing achieves — it is not solely an exercise in finding more carriers.
Inheritance is autosomal dominant, so risk runs down one side of the family and does not skip generations.
Brothers as well as sisters. Male carriers have their own raised risks and pass the variant to half their children.
Sons as well as daughters, for the same reason. Testing is generally deferred until adulthood for adult-onset conditions.
One of them will usually be the carrier, unless the variant arose new in you. Testing them clarifies which side the family branch runs down.
On the carrier parent's side. Each generation halves the probability, but the branch is worth informing.
They carry their own risks — male breast, prostate, pancreatic and, in Lynch syndrome, bowel cancer — and they transmit the variant.
Spouses and in-laws share no genes with you. Only blood relatives on the carrier side are affected.
If you test negative for your family's known variant, you cannot pass it on. That branch closes with you — a genuinely definitive result rather than a partial reassurance.
A relative who tests negative for a known familial variant returns to population risk and can stop worrying — which is why cascade testing is as much about relief as about risk.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Genetic counselling is delivered in-house at CION, including help with the family conversations.
What limits cascade testing is almost never the science. It is that someone has to have a series of difficult conversations, often while still absorbing their own result, frequently with relatives they do not see often — and usually with no support in doing it.
Genetic counselling is delivered in-house at CION, and it covers this side of it rather than only the biology. That means a family letter written to be passed on, help thinking through the order in which to tell people, and somewhere for your relatives to bring their questions rather than those questions coming back to you. The first consultation is free and runs to about 45 minutes.
Because a known variant makes testing targeted, a relative's appointment is usually short and the result straightforward. Where someone tests positive, the management plan is set here too. Where they test negative, they return to population risk and can be discharged — which for many families is the larger part of what this achieves.
Including the family-communication side, not only the biology. A family letter written to be passed on.
Their questions go to a genetics service rather than back to you, which takes real weight off the index case.
One targeted question with a definite answer. Far simpler than the original diagnostic search.
Relatives across Telangana and Andhra Pradesh can be seen near where they live.
The outcomes are unusually clean, because the variant being tested for is already known.
| Result | What it means | What follows |
|---|---|---|
| Positive for the familial variant | They have inherited the family's variant. | Risk management: surveillance, risk-reducing options, and cascade onward to their own children. |
| Negative for the familial variant | A true negative. They did not inherit it. | Return to population risk. Enhanced surveillance can stop. Their branch closes. |
| Untested by choice | Status unknown; risk managed as if potentially positive. | Family history-based management may be offered. The decision can be revisited at any time. |
| Unreachable relative | No information available. | The information has been made available as far as reasonably possible. Not your failure. |
*A negative cascade result is genuinely definitive, unlike a negative first-in-family test — because the exact change being looked for is already known.
It is the systematic testing of blood relatives of someone found to carry a pathogenic cancer-predisposition variant, looking specifically for that identified change. Because the variant is already known, the test is targeted rather than a search: it asks one question and gives a definite yes or no. That makes it faster, considerably cheaper and cleaner to interpret than the original diagnostic test, with no possibility of an uncertain result. It spreads outward from the index case through siblings and children, and then further as each positive result opens a new branch of the family.
Blood relatives on the carrier's side. Siblings and children first, since each has a fifty per cent chance of carrying the variant — and that includes brothers and sons, who carry their own raised risks and transmit the variant to half their own children. Parents are worth testing where possible, since it establishes which side the branch runs down. Aunts, uncles and cousins on the carrier parent's side follow. Relatives by marriage share no genes with you and are not affected. If you test negative for the family variant, your own branch closes with you.
No, and this is a persistent misunderstanding with real consequences. If you have not inherited the variant, you cannot pass it to your children — the chain stops. What looks like skipping a generation is a carrier who never developed cancer: a variant raises risk rather than guaranteeing disease, and a man may carry a BRCA variant, remain entirely well throughout his life, and pass it to half his children. The family appears to skip a generation because nobody in it fell ill, not because the gene was absent. This is also why paternal-side family histories are so often overlooked.
For adult-onset predispositions such as BRCA, testing is generally deferred until adulthood so the person can decide for themselves. The reasoning is practical: nothing would be done differently in childhood, since surveillance does not begin until the twenties at the earliest, so testing a child removes their future choice without offering any benefit. Lynch syndrome is broadly similar. The natural moment to raise it is as a young adult approaches the age at which surveillance or decisions would begin. Telling children that a variant runs in the family, without testing them, is a separate and often earlier conversation.
That is their decision and it should be respected. People decline for varied and often sensible reasons — they would not act differently, they are dealing with something else, or they know how they would live with the knowledge. Your responsibility is making the information available in a form they can act on, not making them act on it. Pressing repeatedly tends to entrench the refusal and damage the relationship without producing a test. What is worth ensuring is that the refusal is informed: that they know effective options exist and that a negative result would return them to population risk. It can always be revisited.
For a relative tested for a known familial variant, a negative result is genuinely definitive — a true negative. They have not inherited the family's variant, their cancer risk returns to that of the general population, and any enhanced surveillance they were having on the basis of family history can generally stop. They also cannot pass the variant to their children, so that branch of the family closes. This differs importantly from a negative first-in-family test, where the responsible gene may simply not have been found. For many families, these negative results are the larger part of what cascade testing delivers.
Yes — genetic counselling is delivered in-house at CION, and it covers the family-communication side as well as the biology. That means a family letter written specifically to be passed on, help thinking through who to tell and in what order, and somewhere for your relatives to take their questions rather than those questions coming back to you. The first consultation is free and runs to about 45 minutes, and relatives across Telangana and Andhra Pradesh can be seen at any of more than 35 centres.